Laigo Bio completes final close of €17m seed financing round
Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m
Read More
Author: Lucy Batizovsky
AEON Biopharma appoints John Bencich as CFO
AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO)
Read More
Axplora announces expansion as newest part of $60m API investment programme
Axplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy
Read More
Helus Pharma appoints Jill Conwell as Chief People Officer
Helus Pharma, a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief People Officer, effective immediately
Read More
DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its SYNTAX platform.
Read More- 1
- 2
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
